HYPERLIVE ENTERTAINMENT AND FANTASTIC GOLDEN RAISE RM50,000 TO SUPPORT YAYASAN NUR JAUHAR’S CHARITY MISSION
KOTA KINABALU, Malaysia, Jan. 2, 2024 /PRNewswire/ — HyperLive Entertainment and Fantastic Golden proudly announce the successful raising of RM50,000 in support of Yayasan Nur Jauhar’s charitable mission. The funds were garnered through the “A Night of Giving” Charity Gala Di
Demron by RST – Advanced Protection Against Today’s Nuclear Threats
MIAMI, Jan. 2, 2024 /PRNewswire/ — Radiation Shield Technologies (RST) proudly marks over two decades of innovation with Demron, a unique fabric designed to safeguard frontline personnel, including military, nuclear industry workers, emergency response teams, Hazmat Teams, firefighters, law e
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Jan. 1, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an
CNOOC Limited Announces Mero2 Project Commences Production
HONG KONG, Jan. 2, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that Mero2 Project has commenced production safely. Mero, Brazil’s third largest oilfield, is located in the Santos Basin pre-salt so
ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024
Enfamil brand Nutramigen A+ LGG Hypoallergenic (infant formula) recalled due to possible presence of Cronobacter sakazakii
OTTAWA, ON, Jan. 1, 2024 /CNW/ – Product: Nutramigen A+ LGG Hypoallergenic (Infant Formula) Issue: Food – Microbial Contamination – Other Distribution: National See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)
ROSEN, A RESPECTED AND LEADING FIRM, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKIN
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive (the “Class Period”), of the important January
CHALLENGE ACCEPTED! RXBAR WILL PAY YOU TO RELOCATE YOUR COUCH THIS WINTER. SIGN THE BAR THE COUCH PLEDGE.
Take the pledge to enter for a chance to win $2,500 to cover the cost of moving and storing a couch and purchasing new home gym equipment. Plus, winners receive a year’s supply of RXBAR bars. CHICAGO, Jan. 1, 2024 /PRNewswire/ — In the cold winter months, the couch is the epitome of wa
SEDG DEADLINE TUESDAY: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages SolarEdge Technologies, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important January 2 Deadline in Securities Class Action – SEDG
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: New York, N.Y., December 31, 2023. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SolarEdge Technologies, Inc. (NASDAQ: SEDG) between February 22, 2022 and October 19, 2023, both dates inclusive (the “Clas
AgriBank Pays Quarterly Dividend and Redeems Preferred Stock
ST. PAUL, Minn., Jan. 1, 2024 /PRNewswire/ — Today, St. Paul-based AgriBank paid a final quarterly cash dividend of $1.7188 per share on its 6.875 percent non-cumulative perpetual series A preferred stock to holders of record as of December 1, 2023. As previously announced, AgriBank will red
